Financial & competing interests disclosure
Fernand Labrie is President and CEO of Endorecherche Inc. (Quebec, Canada), which owns received and pending patents on antiandrogens and performs research on this subject. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.